最小萎缩亚型神经病理替代指标与皮质边缘型阿尔茨海默病亚型的回顾性比较评估
研究在佛罗里达尸检多种族队列中采用两种策略寻找神经影像学定义的最小萎缩亚型的神经病理替代指标:以Braak IV期或高脑重量定义,并与三种皮质边缘亚型比较。结果显示两种替代指标中路易体病频率均增高,作者假设路易体病可能解释最小萎缩病例的认知下降。
要点
- Braak IV期病例教育年限最短、脑重量最高,临床和APOE ε4特征最接近边缘为主型。
- Braak IV期病例中路易体病共病理占32%,高于其他亚型(p=0.005)。
- 高脑重量病例路易体病占31%,高于中、低脑重量组(p=0.042)。
核心结论
- 两种神经病理替代指标中路易体病频率均增高,作者假设路易体病可能解释最小萎缩病例的认知下降。
研究设计与样本
- 在佛罗里达尸检多种族(FLAME)队列中应用的回顾性研究,采用两种策略评估最小萎缩亚型的神经病理替代指标。
主要发现
- Braak IV期病例(n=37)与边缘为主型(n=174)、典型型(n=986)和海马保留型(n=187)阿尔茨海默病相比,教育年限最短(中位12年,组间p<0.001),脑重量最高(中位1,140 g,p=0.002)。
- Braak IV期病例中APOE ε4携带者占75%(p<0.001),遗忘综合征占100%(p<0.001),认知症状起病和死亡年龄较老(中位分别为79岁和85岁,p<0.001)。
- Braak IV期病例中仅5%有杏仁核为主型路易体(观察到的频率最低,p=0.017),而32%有路易体病共病理,高于其他亚型(p=0.005)。
- Braak IV期样本中近一半(47%)有边缘为主型年龄相关TAR DNA结合蛋白43脑病神经病理改变共病理。
- 高脑重量病例(n=201)与中等(n=455)和低(n=203)脑重量病例相比,杏仁核为主型路易体较少(14%,p=0.006),路易体病较多(31%,p=0.042)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Alzheimer disease (AD) is neuropathologically classified into 3 corticolimbic subtypes based on the neurofibrillary tangle distribution throughout the hippocampus and association cortices: limbic predominant, typical, and hippocampal sparing. In vivo, a fourth subtype, dubbed "minimal atrophy," was identified using structural MRI. The objective of this study was to identify a neuropathologic proxy for the neuroimaging-defined minimal atrophy subtype. METHODS: We applied 2 strategies in the Florida Autopsied Multi-Ethnic (FLAME) cohort to evaluate a neuropathologic proxy for the minimal atrophy subtype. In the first strategy, we selected AD cases with a Braak tangle stage IV (Braak IV) because of the relative paucity of neocortical tangle involvement compared with Braak >IV. Braak IV cases were compared with the 3 AD subtypes. In the alternative strategy, typical AD was stratified by brain weight and cases having a relatively high brain weight (>75th percentile) were defined as minimal atrophy. RESULTS: Braak IV cases (n = 37) differed from AD subtypes (limbic predominant [n = 174], typical [n = 986], and hippocampal sparing [n = 187] AD) in having the least years of education (median 12 years, group-wise p < 0.001) and the highest brain weight (median 1,140 g, p = 0.002). Braak IV cases most resembled the limbic predominant cases owing to their high proportion of APOE ε4 carriers (75%, p < 0.001), an amnestic syndrome (100%, p < 0.001), as well as older age of cognitive symptom onset and death (median 79 and 85 years, respectively, p < 0.001). Only 5% of Braak IV cases had amygdala-predominant Lewy bodies (the lowest frequency observed, p = 0.017), whereas 32% had coexisting pathology of Lewy body disease, which was greater than the other subtypes (p = 0.005). Nearly half (47%) of the Braak IV samples had coexisting limbic predominant age-related TAR DNA-binding protein 43 encephalopathy neuropathologic change. Cases with a high brain weight (n = 201) were less likely to have amygdala-predominant Lewy bodies (14%, p = 0.006) and most likely to have Lewy body disease (31%, p = 0.042) compared with those with middle (n = 455) and low (n = 203) brain weight. DISCUSSION: The frequency of Lewy body disease was increased in both neuropathologic proxies of the minimal atrophy subtype. We hypothesize that Lewy body disease may underlie cognitive decline observed in minimal atrophy cases.
引用
- Boon BDC, Labuzan SA, Peng Z, et al. Retrospective Evaluation of Neuropathologic Proxies of the Minimal Atrophy Subtype Compared With Corticolimbic Alzheimer Disease Subtypes. Neurology. 2023. PMID: 37580158. doi:10.1212/WNL.0000000000207685
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。